4.6 Review

Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group

Journal

Publisher

WILEY
DOI: 10.1161/JAHA.120.016115

Keywords

cardiovascular disease prevention; cardiovascular disease risk factors; primary prevention; young adults

Funding

  1. National Heart, Lung, and Blood Institute (NHLBI)
  2. Office of Behavioral and Social Sciences Research
  3. NHLBI [R01HL122144, R01HL127341, HHSN268201800003I, R01HL121230, R21HL145419, R01HL132148, R01HL14866, R01HL136942, R01HL133860, R01HL128666, R01HL130471, R01HL107475]
  4. American Heart Association (AHA) [17SFRN33660752, 18SRG343600001]
  5. US Department of Agriculture's Agricultural Research Service Current Research Information System Award [3092-5-001-057]
  6. AHA [16SFRN28930000, 19SCG34940002, 18SCG34350001, 14SFRN20740001]
  7. NHLBI career development award [K23HL122361]
  8. Kemin Foods
  9. Nexalin Technology
  10. Jazz Pharmaceuticals
  11. National Institute of Minority Health and Health Disparities [R01MD011600]
  12. Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD031921]
  13. American Diabetes Association Pathway to Stop Diabetes Accelerator Award [1-18-ACE-27]
  14. Amarin
  15. Amgen
  16. Astra-Zeneca
  17. Eli Lilly
  18. Esperion
  19. Medicines Company
  20. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK108678, R01DK097364]
  21. NIDDK [R01DK103668, R01DK095078]
  22. Acasti
  23. Merck
  24. Novartis
  25. Novo-Nordisk
  26. Regeneron
  27. Sanofi

Ask authors/readers for more resources

Improvements in cardiovascular disease (CVD) rates among young adults in the past 2 decades have been offset by increasing racial/ethnic and gender disparities, persistence of unhealthy lifestyle habits, overweight and obesity, and other CVD risk factors. To enhance the promotion of cardiovascular health among young adults 18 to 39 years old, the medical and broader public health community must understand the biological, interpersonal, and behavioral features of this life stage. Therefore, the National Heart, Lung, and Blood Institute, with support from the Office of Behavioral and Social Science Research, convened a 2-day workshop in Bethesda, Maryland, in September 2017 to identify research challenges and opportunities related to the cardiovascular health of young adults. The current generation of young adults live in an environment undergoing substantial economic, social, and technological transformations, differentiating them from prior research cohorts of young adults. Although the accumulation of clinical and behavioral risk factors for CVD begins early in life, and research suggests early risk is an important determinant of future events, few trials have studied prevention and treatment of CVD in participants <40 years old. Building an evidence base for CVD prevention in this population will require the engagement of young adults, who are often disconnected from the healthcare system and may not prioritize long-term health. These changes demand a repositioning of existing evidence-based treatments to accommodate new sociotechnical contexts. In this article, the authors review the recent literature and current research opportunities to advance the cardiovascular health of today's young adults.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available